EXEL logo

Exelixis (EXEL) Company Overview

Profile

Full Name:

Exelixis, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 17, 2000

Indexes:

Not included

Description:

Exelixis is a biotechnology company focused on developing cancer treatments. They create innovative medicines that target specific cancer cells, aiming to improve patient outcomes. Their research includes drug discovery and clinical trials to find effective therapies for various types of cancer.

Key Details

Price

$38.55

Annual Revenue

$2.17 B(+18.49% YoY)

Annual EPS

$1.76(+170.77% YoY)

Beta

0.25

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Feb 11, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 Wells Fargo
Equal-Weight
Feb 13, 25 HC Wainwright & Co.
Buy
Feb 13, 25 Barclays
Equal-Weight
Feb 12, 25 Stifel
Hold
Feb 12, 25 Stephens & Co.
Equal-Weight
Feb 12, 25 Piper Sandler
Overweight
Feb 12, 25 Guggenheim
Buy
Feb 12, 25 Citigroup
Buy
Jan 28, 25 UBS
Neutral
Jan 27, 25 Truist Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Exelixis?
  • Does Exelixis pay dividends?
  • What sector is Exelixis in?
  • What industry is Exelixis in?
  • What country is Exelixis based in?
  • When did Exelixis go public?
  • Is Exelixis in the S&P 500?
  • Is Exelixis in the NASDAQ 100?
  • Is Exelixis in the Dow Jones?
  • When was Exelixis's last earnings report?
  • When does Exelixis report earnings?
  • Should I buy Exelixis stock now?

What is the ticker symbol for Exelixis?

The ticker symbol for Exelixis is NASDAQ:EXEL

Does Exelixis pay dividends?

No, Exelixis does not pay dividends

What sector is Exelixis in?

Exelixis is in the Healthcare sector

What industry is Exelixis in?

Exelixis is in the Biotechnology industry

What country is Exelixis based in?

Exelixis is headquartered in United States

When did Exelixis go public?

Exelixis's initial public offering (IPO) was on April 17, 2000

Is Exelixis in the S&P 500?

No, Exelixis is not included in the S&P 500 index

Is Exelixis in the NASDAQ 100?

No, Exelixis is not included in the NASDAQ 100 index

Is Exelixis in the Dow Jones?

No, Exelixis is not included in the Dow Jones index

When was Exelixis's last earnings report?

Exelixis's most recent earnings report was on Feb 11, 2025

When does Exelixis report earnings?

The next expected earnings date for Exelixis is Apr 30, 2025

Should I buy Exelixis stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions